LCMS webinars focusing on LC/HRMS - page 46

Join us for this exciting new demo series where we take you into our application laboratories to see the SELECT SERIES Cyclic IMS in action and explore different workflows from the beginning to the end.

This online event will focus on improving the collection and processing of multi-omics data during the drug discovery process to enable the development of more effective drugs.

This online event will focus on improving the collection and processing of multi-omics data during the drug discovery process to enable the development of more effective drugs.

3 Topics: The Role of Second Messenger in Mycobacterial Drug Tolerance; A Hybrid Cytoplasmic–mitochondrial Tricarboxylic Acid Cycle in Prostate Cancer; Metabolic Vulnerabilities in Breast Cancer.

The novel fragmentation technique, EAD of the ZenoTOF 7600 system (SCIEX), was employed for peptide mapping of a multispecific monoclonal antibody (mAb) as well as IgG1 and IgG4 mAb samples.

Insights into the use of HRMS across a variety of fields, namely food safety, forensics and clinical research.

Here, Drs. Peter Nemes and Ben Orsburn will share recent advances in the field, providing insight to new biological discoveries and post-translational modifications at single-cell resolution.

New methods, techniques and efficient data analysis software in liquid chromatography-tandem mass spectrometry (LC-MS/MS) hold the key for accelerating the development of NGBs and increasing their availability.

We will introduce two different mass spectrometer systems and discuss how these could fit into seized drug analysis workflows and improve sample throughput.

The electron activated dissociation (EAD) platform method offers the capability for isomer differentiation, and the speed, reproducibility and sensitivity for confident quantification of PQAs.